E172-1 Why Big Brands Are Quietly Exploring Cannabis and Psychedelics - Skunk Works Nature AI with David Traylor Part 1

E172-1 Why Big Brands Are Quietly Exploring Cannabis and Psychedelics - Skunk Works Nature AI with David Traylor Part 1

April 7, 2026 · 21 min

About this episode

David Traylor discusses how big brands are exploring cannabis and psychedelics through Skunk Works Nature AI.

Can big brands explore cannabis, & psychedelics without saying it out loud? What happens when cannabis and natural compounds expertise, a global network, and AI-driven product strategy collide? David Traylor of Golden Eagle Partners introduces Skunk Works Nature AI. This new venture helps major consumer brands quietly explore cannabinoids and other natural compounds. Does a large beverage company want a CBG infused drink to help University Students get over their exam anxiety? Does a Fast-Moving Consumer Goods Brand want a toothpaste with CBN to help people sleep? Does a cosmetics company want a micro-dosed psychedelic lipstick for when an artist or CEO needs some creativity on demand? Large companies may be canna-curious but stigma still slows innovation. The confidential advice and expertise of Skunk Works Nature AI should bring serious players into the space. The future belongs to evidence-based product development built around cannabinoids, alkaloids, terpenes, and other natural compounds. David also discusses the capital crunch in cannabis, why so many firms have exited the sector, and a fascinating discussion about cannabis language and policy, including David’s clearer…

More episodes of Reefer MEDness

Explore listener stats, chart rankings, contacts and more on the Reefer MEDness podcast page.